β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway

Sourish Ghosh, Teegan A Dellibovi-Ragheb, Adeline Kerviel, Eowyn Pak, Qi Qiu, Matthew Fisher, Peter M Takvorian, Christopher Bleck, Victor W Hsu, Anthony R Fehr, Stanley Perlman, Sooraj R Achar, Marco R Straus, Gary R Whittaker, Cornelis A M de Haan, John Kehrl, Grégoire Altan-Bonnet, Nihal Altan-Bonnet

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

β-Coronaviruses are a family of positive-strand enveloped RNA viruses that includes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Much is known regarding their cellular entry and replication pathways, but their mode of egress remains uncertain. Using imaging methodologies and virus-specific reporters, we demonstrate that β-coronaviruses utilize lysosomal trafficking for egress rather than the biosynthetic secretory pathway more commonly used by other enveloped viruses. This unconventional egress is regulated by the Arf-like small GTPase Arl8b and can be blocked by the Rab7 GTPase competitive inhibitor CID1067700. Such non-lytic release of β-coronaviruses results in lysosome deacidification, inactivation of lysosomal degradation enzymes, and disruption of antigen presentation pathways. β-Coronavirus-induced exploitation of lysosomal organelles for egress provides insights into the cellular and immunological abnormalities observed in patients and suggests new therapeutic modalities.

Original languageEnglish
Pages (from-to)1520-1535.e14
JournalCell
Volume183
Issue number6
Early online date2020
DOIs
Publication statusPublished - 10 Dec 2020

Keywords

  • coronavirus
  • SARS-CoV-2
  • viral egress
  • lysosome
  • pH
  • viral immunology
  • antigen presentation
  • acidification/deacidification ARL8b
  • Rab7
  • CD1067700

Fingerprint

Dive into the research topics of 'β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway'. Together they form a unique fingerprint.

Cite this